2008
DOI: 10.1371/journal.pone.0003997
|View full text |Cite
|
Sign up to set email alerts
|

The Growth and Tumor Suppressors NORE1A and RASSF1A Are Targets for Calpain-Mediated Proteolysis

Abstract: BackgroundNORE1A and RASSF1A are growth and tumour suppressors inactivated in a variety of cancers. Methylation of NORE1A and RASSF1A promoters is the predominant mechanism for downregulation of these proteins; however, other mechanisms are likely to exist.Methodology/Principal FindingsHere we describe a proteolysis of NORE1A and RASSF1A by calpains as alternative mechanism of their downregulation. Extracts of H358 cell line, a human bronchoalveolar carcinoma, and H460, a large cell carcinoma, were capable of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
17
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(17 citation statements)
references
References 31 publications
0
17
0
Order By: Relevance
“…Inhibits cell growth, arrests cell cycle [58,62] Involved in actin cytoskeleton organization [148] Induces apoptosis [58,62,145] Suppresses transcriptional activity of NFjB [181] Inhibits MST2 activity [93] K-Ras [62] PAR4 [64] MST1 [66,177] MST2 [177] Yes [67] growth retardation, systematic haematopoietic anomalies, defects in osteoclast and osteoblast differentiation 3 12q14. 1 …”
Section: Rassf1amentioning
confidence: 99%
See 1 more Smart Citation
“…Inhibits cell growth, arrests cell cycle [58,62] Involved in actin cytoskeleton organization [148] Induces apoptosis [58,62,145] Suppresses transcriptional activity of NFjB [181] Inhibits MST2 activity [93] K-Ras [62] PAR4 [64] MST1 [66,177] MST2 [177] Yes [67] growth retardation, systematic haematopoietic anomalies, defects in osteoclast and osteoblast differentiation 3 12q14. 1 …”
Section: Rassf1amentioning
confidence: 99%
“…Alternative to epigenetic silencing, RASSF5A can be downregulated through proteolysis catalyzed by calpain proteins, offering a means for tumor cells to flourish and escape growth inhibition [148]. RASSF5C promoter methylation is a rare event, possibly because its expression is limited to lymphoid tissue.…”
Section: Thementioning
confidence: 99%
“…Additionally, NORE1A is often down regulated in tumors by epigenetic inactivation via promoter hypermethylation and can undergo loss of heterozygosity in a rare form of kidney cancer [14,137]. At a protein level, NORE1A can also be down regulated in tumor cells by calpains and by ubiquitination [138,139]. In liver cancer, more malignant primary tumor samples have an inverse correlation with NORE1A expression, whereas normal liver tissue expresses NORE1A [140].…”
Section: The Nore1a Tumor Suppressor (Rassf5)mentioning
confidence: 99%
“…can also be regulated at the mRNA [138] and protein levels [139]. Protein array analysis from breast tissue tumor samples would be necessary to determine more accurate NORE1A/BRCA1 expression levels.…”
Section: Nore1a Appears To Be Acting As a Direct Communication Link Bmentioning
confidence: 99%